典型文献
PRKCDBP Methylation is a Potential and Promising Candidate Biomarker for Non-small Cell Lung Cancer
文献摘要:
Background and objectives: The occurrence and development of lung cancer are closely linked to epigenetic modification. Abnormal DNA methylation in the CpG island region of genes has been found in many cancers. Protein kinase C delta binding protein (PRKCDBP) is a potential tumor suppressor and its epigenetic changes are found in many human malignancies. This study investigated the possibility of PRKCDBP methylation as a potential biomarker for non-small cell lung cancer (NSCLC).Methods: We measured the methylation levels of PRKCDBP in the three groups of NSCLC tissues. Promoter activity was measured by the dual luciferase assay, with 5'-aza-deoxycytidine to examine the effect of demethylation on the expression level of PRKCDBP. Results: The methylation levels of PRKCDBP in tumor tissues and 3 cm para-tumor were higher than those of distant (>10 cm) non-tumor tissues. Receiver operating characteristic (ROC) curve analysis between tumor tissues and distant non-tumor tissues showed that the area under the line (AUC) was 0.717. Dual luciferase experiment confirmed that the promoter region was able to promote gene expression. Meanwhile, in vitro methylation of the fragment (PRKCDBP_Me) could significantly reduce the promoter activity of the fragment. Demethylation of 5'-aza-deoxycytidine in lung cancer cell lines A549 and H1299 showed a significant up-regulation of PRKCDBP mRNA levels.Conclusion: PRKCDBP methylation is a potential and promising candidate biomarker for non-small cell lung cancer.
文献关键词:
中图分类号:
作者姓名:
Jing LI;Lin QI;Mingfang ZHANG;Caiyun YAO;Jinan FENG;Zhonghua ZHENG;Chujia CHEN;Shiwei DUAN;Yuanlin QI
作者机构:
School of Basic Medical Sciences,Fujian Medical University,Fuzhou 350122,China;Medical Genetics Center,School of Medicine,Ningbo University,Ningbo 315211,China
文献出处:
引用格式:
[1]Jing LI;Lin QI;Mingfang ZHANG;Caiyun YAO;Jinan FENG;Zhonghua ZHENG;Chujia CHEN;Shiwei DUAN;Yuanlin QI-.PRKCDBP Methylation is a Potential and Promising Candidate Biomarker for Non-small Cell Lung Cancer)[J].中国肺癌杂志,2022(02):78-85
A类:
PRKCDBP,Demethylation
B类:
Methylation,Potential,Promising,Candidate,Biomarker,Non,small,Cell,Lung,Cancer,Background,objectives,occurrence,development,lung,closely,linked,epigenetic,modification,Abnormal,CpG,island,region,genes,has,been,found,many,cancers,Protein,kinase,delta,binding,protein,potential,tumor,suppressor,its,changes,human,malignancies,This,study,investigated,possibility,biomarker,cell,NSCLC,Methods,We,measured,levels,three,groups,tissues,Promoter,activity,was,by,dual,luciferase,assay,aza,deoxycytidine,examine,effect,demethylation,expression,Results,para,were,higher,than,those,distant,Receiver,operating,characteristic,curve,analysis,between,showed,that,area,under,Dual,experiment,confirmed,promoter,able,Meanwhile,vitro,fragment,could,significantly,reduce,lines,A549,H1299,regulation,Conclusion,promising,candidate
AB值:
0.495347
相似文献
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。